---
figid: PMC9185805__etm-24-01-11366-g00
pmcid: PMC9185805
image_filename: etm-24-01-11366-g00.jpg
figure_link: /pmc/articles/PMC9185805/figure/f1-ETM-24-1-11366/
number: Figure 1
figure_title: ''
caption: 'Changes in body weight and blood glucose of diabetic mice during treatments.
  (A) Weight per week (g). (B) Glucose level after feeding per week. Data are presented
  as the mean ± SD (n=4/group). *P<0.05 vs. NGT; #P<0.05 vs. STZ; †P<0.05 vs. INS;
  ‡P<0.05 vs. LRG. STZ, saline treated type 1 diabetes group; INS, insulin treatment
  group; LRG, liraglutide treatment group; INS + LRG, insulin and liraglutide treatment
  group; NGT, normal glucose tolerance group.'
article_title: Insulin and liraglutide attenuate brain pathology in diabetic mice
  by enhancing the Wnt/β-catenin signaling pathway.
citation: Yuan Zhao, et al. Exp Ther Med. 2022 Jul;24(1):439.
year: '2022'

doi: 10.3892/etm.2022.11366
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- liraglutide
- insulin
- type 1 diabetes mellitus
- brain apoptosis
- Wnt/β-Catenin signaling pathway

---
